Global Hematology Controls Market Growth 2025-2031

The global Hematology Controls market size is predicted to grow from US$ 361 million in 2025 to US$ 547 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.

Hematology controls are used to assess the precision of instruments such as hematology analyzers, thereby ensuring valid patient results and fulfilling accreditation requirements. The controls are commonly found in the clinical diagnostics laboratory.

Global key players of Hematology Controls include Sysmex, Danaher, etc. Global top 3 companies hold a share about 70%. Asia Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share about 25% and 20%. In terms of product, 3-Part is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospital, with a share over 60%.

LP Information, Inc. (LPI) ' newest research report, the “Hematology Controls Industry Forecast” looks at past sales and reviews total world Hematology Controls sales in 2024, providing a comprehensive analysis by region and market sector of projected Hematology Controls sales for 2025 through 2031. With Hematology Controls sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematology Controls industry.

This Insight Report provides a comprehensive analysis of the global Hematology Controls landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hematology Controls portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hematology Controls market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematology Controls and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematology Controls.

This report presents a comprehensive overview, market shares, and growth opportunities of Hematology Controls market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
3-Part Hematology Controls
5-Part Hematology Controls
Others

Segmentation by Application:
Hospital
Independent Lab
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sysmex
Danaher
Bio-Rad
Mindray
Abbott
Horiba
Boule
Diatron

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hematology Controls market?

What factors are driving Hematology Controls market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hematology Controls market opportunities vary by end market size?

How does Hematology Controls break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.